Virtus Alfasigma Tournament and Race For The Cure. Double events that saw the people of Alfasigma engaged in a weekend dedicated to youth, wellness and prevention.
CARNITENE®[1] (L-carnitine), the blockbuster product of Alfasigma Group, was approved for marketing in China in the early 21stcentury. Since July 1, the right to distribute the product in China has been held by Kyuan Xinhai (Beijing) Medical Products Trade Co., Ltd.
SOFAR is an Italian company specializing in pharmaceutical products, food supplements and medical devices.
Alfasigma consolidates its leadership in the gastrointestinal area and the research focus on the microbiota.
The acquisition is expected to be completed in October 2022.
Gastrointestinal therapeutics are our specialty. Everyday we strive to give a concrete answer to functional gastro-intestinal disorders, gastro-oesophageal reflux disorder, hepatic encephalopathy and chronic liver disease (cirrhosis).
Vascular investigation is a company corporate mission. Venous diseases, lower extremity artery disease, diabetic microangiopathies and ventricular arrhythmia are the main pathologies in which we offer solutions.
In the metabolic area, our R&D has developed Carnitine, an amino acid derivative whose insufficiency can impair the metabolism of essential tissues, such as those of the heart and muscles.
With our supplements, we are responding to the demand for a vast range of elements aimed at neural tissue well-being, recovery of muscle tone and combating physical and mental fatigue.
doctorAsyou provides physicians and researchers with easier and smarter access to the most relevant EBM (Evidence Based Medicine) topics.
The doctorAsyou search engine is updated daily and returns over 30 million abstracts, combining the three most authoritative databases in the world: Pubmed, ICRTP, Clinicaltrials.gov
lf you're searching for a scientific article, a paper, an abstract or more, try to use it directly from this search bar.
You’re entering Alfasigma global website
I agree